Data from the first stage of a phase 3 study show significant reductions in proteinuria among patients treated with telitacicept.
IgA nephropathy (IgAN), also known as Berger disease, occurs when high levels of immunoglobulin A (IgA) antibodies accumulate in the kidneys. This causes inflammation and scarring in the glomeruli, ...
You can take steps to reduce protein in your urine and maintain kidney function longer when living with IgA nephropathy. IgA nephropathy (IgAN) develops when your body makes too much of an antibody ...
HOUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients with IgA nephropathy, interim findings from the phase III ORIGIN 3 trial ...
Hosted on MSN
5 early signs and symptoms of IgA nephropathy
Signs and symptoms of IgA nephropathy vary among individuals and may not manifest for years, even decades. If symptoms are present, common and early ones include blood in the urine, foamy urine, ...
Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs) in the glomerular mesangium, leading to mesangial ...
IgA nephropathy can shorten life expectancy by 10 years on average. Life expectancy can depend on several factors, including kidney function at diagnosis, protein levels in the urine, age, other ...
Elevated tissue transglutaminase immunoglobulin A (tTG-IgA) in isolation is insufficient to diagnose celiac disease in children, a large pediatric cohort study in North America found. Because tTG-IgA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results